Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.

Nigro S, Barbagallo G, Bianco MG, Morelli M, Arabia G, Quattrone A, Gasparini S, Cascini GL, Quattrone A.

Parkinsonism Relat Disord. 2019 Oct 22;69:23-29. doi: 10.1016/j.parkreldis.2019.10.020. [Epub ahead of print]

PMID:
31665684
2.

Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease.

Nigro S, Bordier C, Cerasa A, Nisticò R, Olivadese G, Vescio B, Bianco MG, Fiorillo A, Barbagallo G, Crasà M, Quattrone A, Morelli M, Arabia G, Augimeri A, Nicolini C, Bifone A, Quattrone A.

Parkinsonism Relat Disord. 2019 Oct;67:14-20. doi: 10.1016/j.parkreldis.2019.09.006. Epub 2019 Sep 8.

PMID:
31621599
3.

Value of Multimodal Imaging Approach to Diagnosis of Neurosarcoidosis.

Sammarra I, Barbagallo G, Labate A, Mondello B, Albonico G, Maisano M, Cascini GL, Quattrone A, Gambardella A.

Brain Sci. 2019 Sep 21;9(10). pii: E243. doi: 10.3390/brainsci9100243.

4.

The embodiment of language in tremor-dominant Parkinson's disease patients.

Nisticò R, Cerasa A, Olivadese G, Dalla Volta R, Crasà M, Vasta R, Gramigna V, Vescio B, Barbagallo G, Chiriaco C, Quattrone A, Salsone M, Novellino F, Arabia G, Nicoletti G, Morelli M, Quattrone A.

Brain Cogn. 2019 Oct;135:103586. doi: 10.1016/j.bandc.2019.103586. Epub 2019 Jul 18.

PMID:
31326764
5.

Intracellular FMRpolyG-Hsp70 complex in fibroblast cells from a patient affected by fragile X tremor ataxia syndrome.

Bonapace G, Gullace R, Concolino D, Iannello G, Procopio R, Gagliardi M, Arabia G, Barbagallo G, Lupo A, Manfredini LI, Annesi G, Quattrone A.

Heliyon. 2019 Jun 20;5(6):e01954. doi: 10.1016/j.heliyon.2019.e01954. eCollection 2019 Jun.

6.

Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [18F] FDG a specific biomarker in these patients?

Chiaravalloti A, Barbagallo G, Martorana A, Castellano AE, Ursini F, Schillaci O.

Eur J Nucl Med Mol Imaging. 2019 Aug;46(9):1796-1805. doi: 10.1007/s00259-019-04379-4. Epub 2019 Jun 14.

PMID:
31201430
7.

Does levodopa have a disease-modifying effect in Parkinson's disease? Evidence from a delayed-start trial.

Barbagallo G, Quattrone A.

Mov Disord. 2019 Jun;34(6):820. doi: 10.1002/mds.27686. Epub 2019 Apr 8. No abstract available.

PMID:
30958571
8.

Imaging counterpart of postural instability and vertical ocular dysfunction in patients with PSP: A multimodal MRI study.

Quattrone A, Caligiuri ME, Morelli M, Nigro S, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Vaccaro MG, Sabatini U, Vescio V, Stanà C, Rocca F, Caracciolo M, Quattrone A.

Parkinsonism Relat Disord. 2019 Jun;63:124-130. doi: 10.1016/j.parkreldis.2019.02.022. Epub 2019 Feb 19.

PMID:
30803901
9.

Refining initial diagnosis of Parkinson's disease after follow-up: A 4-year prospective clinical and magnetic resonance imaging study.

Quattrone A, Morelli M, Vescio B, Nigro S, Le Piane E, Sabatini U, Caracciolo M, Vescio V, Quattrone A, Barbagallo G, Stanà C, Nicoletti G, Arabia G, Nisticò R, Novellino F, Salsone M.

Mov Disord. 2019 Apr;34(4):487-495. doi: 10.1002/mds.27621. Epub 2019 Feb 13.

10.

Brain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT study.

D'Angelo S, Chiaravalloti A, Ursini F, Barbagallo G, Gilio M, Leccese P, De Giorgio R, Di Giorgio E, Schillaci O.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):148-149. Epub 2018 Dec 14. No abstract available.

11.

In vivo evidence for decreased scyllo-inositol levels in the supplementary motor area of patients with Progressive Supranuclear Palsy: A proton MR spectroscopy study.

Barbagallo G, Morelli M, Quattrone A, Chiriaco C, Vaccaro MG, Gullà D, Rocca F, Caracciolo M, Novellino F, Sarica A, Arabia G, Sabatini U, Quattrone A.

Parkinsonism Relat Disord. 2019 May;62:185-191. doi: 10.1016/j.parkreldis.2018.12.008. Epub 2018 Dec 11.

PMID:
30558837
12.

Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.

Fusilli C, Migliore S, Mazza T, Consoli F, De Luca A, Barbagallo G, Ciammola A, Gatto EM, Cesarini M, Etcheverry JL, Parisi V, Al-Oraimi M, Al-Harrasi S, Al-Salmi Q, Marano M, Vonsattel JG, Sabatini U, Landwehrmeyer GB, Squitieri F.

Lancet Neurol. 2018 Nov;17(11):986-993. doi: 10.1016/S1474-4422(18)30294-1. Epub 2018 Sep 19.

PMID:
30243861
13.

Neurobiology of placebo effect in Parkinson's disease: What we have learned and where we are going.

Quattrone A, Barbagallo G, Cerasa A, Stoessl AJ.

Mov Disord. 2018 Aug;33(8):1213-1227. doi: 10.1002/mds.27438. Review.

PMID:
30230624
14.

A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Sep;54:3-8. doi: 10.1016/j.parkreldis.2018.07.016. Epub 2018 Jul 25.

PMID:
30068492
15.

Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Arabia G, Lupo A, Manfredini LI, Vescio B, Nisticò R, Barbagallo G, Salsone M, Morelli M, Novellino F, Nicoletti G, Quattrone A, Cascini GL, Louis ED, Quattrone A.

Parkinsonism Relat Disord. 2018 Nov;56:20-26. doi: 10.1016/j.parkreldis.2018.06.005. Epub 2018 Jun 5.

PMID:
29885986
16.

Ageing effect on 18F-DOPA and 123I-MIBG uptake: a cross-sectional study.

Chiaravalloti A, Barbagallo G, Ricci M, Sannino P, Karalis G, Ursini F, Schillaci O.

Nucl Med Commun. 2018 Jun;39(6):539-544. doi: 10.1097/MNM.0000000000000835.

PMID:
29649065
17.

The placebo effect on resting tremor in Parkinson's disease: an electrophysiological study.

Barbagallo G, Nisticò R, Vescio B, Cerasa A, Olivadese G, Nigro S, Crasà M, Quattrone A, Bianco MG, Morelli M, Augimeri A, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Parkinsonism Relat Disord. 2018 Jul;52:17-23. doi: 10.1016/j.parkreldis.2018.03.012. Epub 2018 Mar 14.

PMID:
29551396
18.

MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.

Péran P, Barbagallo G, Nemmi F, Sierra M, Galitzky M, Traon AP, Payoux P, Meissner WG, Rascol O.

Mov Disord. 2018 Apr;33(4):600-608. doi: 10.1002/mds.27307. Epub 2018 Feb 23.

PMID:
29473662
19.

Coupled Imaging with [18F]FBB and [18F]FDG in AD Subjects Show a Selective Association Between Amyloid Burden and Cortical Dysfunction in the Brain.

Chiaravalloti A, Castellano AE, Ricci M, Barbagallo G, Sannino P, Ursini F, Karalis G, Schillaci O.

Mol Imaging Biol. 2018 Aug;20(4):659-666. doi: 10.1007/s11307-018-1167-1.

PMID:
29404839
20.

Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.

Barbagallo G, Arabia G, Novellino F, Nisticò R, Salsone M, Morelli M, Rocca F, Quattrone A, Caracciolo M, Sabatini U, Cherubini A, Quattrone A.

Parkinsonism Relat Disord. 2018 Feb;47:57-63. doi: 10.1016/j.parkreldis.2017.11.345. Epub 2017 Nov 28.

PMID:
29203059

Supplemental Content

Loading ...
Support Center